Literature DB >> 28865842

Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.

Evangelos Bouros1, Eirini Filidou2, Konstantinos Arvanitidis3, Dimitrios Mikroulis4, Paschalis Steiropoulos5, George Bamias6, Demosthenes Bouros7, George Kolios8.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by infiltration of inflammatory cells, excessive collagen production and accumulation of myofibroblasts. We explored the possible role of subepithelial lung myofibroblasts (SELMs) in the development of fibrosis in IPF. SELMs, isolated from surgical specimens of healthy lung tissue, were cultured with pro-inflammatory factors or bronchoalveolar lavage fluid (BALF) from patients with IPF or idiopathic non-specific interstitial pneumonia (iNSIP) and their fibrotic activity was assessed. Stimulation of SELMs with pro-inflammatory factors induced a significant increase of Tissue Factor (TF) and Tumor necrosis factor-Like cytokine 1 A (TL1A) expression and collagen production in culture supernatants. Stimulation with BALF from IPF patients with mild to moderate, but not severe disease, and from iNSIP patients induced a significant increase of TF expression. BALF from all IPF patients induced a significant increase of TL1A expression and collagen production, while BALF from iNSIP patients induced a significant increase of TL1A, but not of collagen production. Interestingly, TGF-β1 and BALF from all IPF, but not iNSIP patients, induced a significant increase in SELMs migration. In conclusion, BALF from IPF patients induces fibrotic activity in lung myofibroblasts, similar to mediators associated with lung fibrosis, indicating a key role of SELMs in IPF.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extracellular matrix; Idiopathic pulmonary fibrosis; Lung fibrosis; Myofibroblasts; TL1A; Tissue factor

Mesh:

Substances:

Year:  2017        PMID: 28865842     DOI: 10.1016/j.pupt.2017.08.012

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  8 in total

Review 1.  Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Authors:  Martina Korfei; Poornima Mahavadi; Andreas Guenther
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

2.  Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells.

Authors:  Eirini Filidou; Leonidas Kandilogiannakis; Gesthimani Tarapatzi; Michail Spathakis; Paschalis Steiropoulos; Dimitrios Mikroulis; Konstantinos Arvanitidis; Vasilis Paspaliaris; George Kolios
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  PathWalks: identifying pathway communities using a disease-related map of integrated information.

Authors:  Evangelos Karatzas; Margarita Zachariou; Marilena M Bourdakou; George Minadakis; Anastasis Oulas; George Kolios; Alex Delis; George M Spyrou
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

4.  Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells.

Authors:  Andreas Guenther; Martina Korfei; Oleksiy Klymenko; Martin Huehn; Jochen Wilhelm; Roxana Wasnick; Irina Shalashova; Clemens Ruppert; Ingrid Henneke; Stefanie Hezel; Katharina Guenther; Poornima Mahavadi; Christos Samakovlis; Werner Seeger
Journal:  J Mol Med (Berl)       Date:  2019-04-26       Impact factor: 4.599

Review 5.  TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.

Authors:  Vassilis Valatas; George Kolios; Giorgos Bamias
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

6.  TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial-Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma.

Authors:  Dong Zhang; Hui Yang; Xue-Li Dong; Jin-Tao Zhang; Xiao-Fei Liu; Yun Pan; Jian Zhang; Jia-Wei Xu; Zi-Han Wang; Wen-Jing Cui; Liang Dong
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

7.  Effect of Hypoxia in the Transcriptomic Profile of Lung Fibroblasts from Idiopathic Pulmonary Fibrosis.

Authors:  Yair Romero; Yalbi Itzel Balderas-Martínez; Miguel Angel Vargas-Morales; Manuel Castillejos-López; Joel Armando Vázquez-Pérez; Jazmín Calyeca; Luz María Torres-Espíndola; Nelly Patiño; Angel Camarena; Ángeles Carlos-Reyes; Edgar Flores-Soto; Guadalupe León-Reyes; Martha Patricia Sierra-Vargas; Iliana Herrera; Erika Rubí Luis-García; Víctor Ruiz; Rafael Velázquez-Cruz; Arnoldo Aquino-Gálvez
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

8.  Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.

Authors:  Martina Korfei; Daniel Stelmaszek; BreAnne MacKenzie; Sylwia Skwarna; Shashipavan Chillappagari; Anna C Bach; Clemens Ruppert; Shigeki Saito; Poornima Mahavadi; Walter Klepetko; Ludger Fink; Werner Seeger; Joseph A Lasky; Soni S Pullamsetti; Oliver H Krämer; Andreas Guenther
Journal:  PLoS One       Date:  2018-11-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.